(Q35921869)

26870931

11 August 2017

title

Targeting Dysbiosis for the Treatment of Liver Disease (English)

1 reference

11 August 2017

1 reference

2

Amir Zarrinpar

0 references

author name string

Gobind Anand

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6658186&resulttype=core&format=json

15 May 2020

Amir Zarrinpar

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6658186&resulttype=core&format=json

15 May 2020

Rohit Loomba

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6658186&resulttype=core&format=json

15 May 2020

publication date

12 February 2016

1 reference

26870931

Seminars in Liver Disease

11 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6658186&resulttype=core&format=json

15 May 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6658186&resulttype=core&format=json

15 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6658186&resulttype=core&format=json

15 May 2020

page(s)

37-47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6658186&resulttype=core&format=json

Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp.

15 May 2020

cites work

1 reference

12 December 2020

Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease.

1 reference

12 December 2020

Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis

1 reference

12 December 2020

Bacterial translocation of enteric organisms in patients with cirrhosis

1 reference

12 December 2020

Pro- and anti-inflammatory gene expression in the murine small intestine and liver after chronic exposure to alcohol

1 reference

12 December 2020

Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis

1 reference

12 December 2020

Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites

1 reference

12 December 2020

Gastrointestinal effects of prebiotics

1 reference

12 December 2020

Gut-liver axis: a new point of attack to treat chronic liver damage?

1 reference

12 December 2020

Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia

1 reference

12 December 2020

Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells

1 reference

12 December 2020

TREATMENT OF HEPATIC ENCEPHALOPATHY BY ALTERATION OF INTESTINAL FLORA WITH LACTOBACILLUS ACIDOPHILUS.

1 reference

12 December 2020

Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis

1 reference

12 December 2020

Epidermal growth factor prevents acetaldehyde-induced paracellular permeability in Caco-2 cell monolayer

1 reference

12 December 2020

Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway

1 reference

12 December 2020

L-Glutamine ameliorates acetaldehyde-induced increase in paracellular permeability in Caco-2 cell monolayer

1 reference

12 December 2020

The gut microbiota as an environmental factor that regulates fat storage

1 reference

12 December 2020

Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases.

1 reference

12 December 2020

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

1 reference

12 December 2020

Pattern recognition receptors: a contemporary view on liver diseases.

1 reference

12 December 2020

Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice

1 reference

12 December 2020

Acetaldehyde dissociates the PTP1B-E-cadherin-beta-catenin complex in Caco-2 cell monolayers by a phosphorylation-dependent mechanism

1 reference

12 December 2020

An obesity-associated gut microbiome with increased capacity for energy harvest

1 reference

12 December 2020

Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis

1 reference

12 December 2020

The effect of probiotics on gut flora, level of endotoxin and Child-Pugh score in cirrhotic patients: results of a double-blind randomized study.

1 reference

12 December 2020

Acetaldehyde-induced barrier disruption and paracellular permeability in Caco-2 cell monolayer

1 reference

12 December 2020

The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88.

1 reference

12 December 2020

The effect of a probiotic on hepatic steatosis

1 reference

12 December 2020

Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease

1 reference

12 December 2020

Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study

1 reference

12 December 2020

Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis

1 reference

12 December 2020

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.

1 reference

12 December 2020

Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease.

1 reference

12 December 2020

Management of adult patients with ascites due to cirrhosis: an update

1 reference

12 December 2020

Endotoxemia and gut barrier dysfunction in alcoholic liver disease

1 reference

12 December 2020

Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats

1 reference

12 December 2020

Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy

1 reference

12 December 2020

Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate

1 reference

12 December 2020

Alcoholic liver disease.

1 reference

12 December 2020

Rifaximin treatment in hepatic encephalopathy

1 reference

12 December 2020

Protective effects of Lactobacillus paracasei F19 in a rat model of oxidative and metabolic hepatic injury

1 reference

12 December 2020

Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy

1 reference

12 December 2020

Systemic gut microbial modulation of bile acid metabolism in host tissue compartments

1 reference

12 December 2020

Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis.

1 reference

12 December 2020

The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation

1 reference

12 December 2020

Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.

1 reference

12 December 2020

Characterization of fecal microbial communities in patients with liver cirrhosis.

1 reference

12 December 2020

Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis.

1 reference

12 December 2020

Small intestinal bacterial overgrowth: a comprehensive review

1 reference

12 December 2020

Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial

1 reference

12 December 2020

Probiotics for patients with hepatic encephalopathy

1 reference

12 December 2020

Colonic microbiome is altered in alcoholism.

1 reference

12 December 2020

Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity

1 reference

12 December 2020

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

1 reference

12 December 2020

Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis

1 reference

12 December 2020

FXR signaling in the enterohepatic system

1 reference

12 December 2020

Diversity, stability and resilience of the human gut microbiota

1 reference

12 December 2020

Functional interactions between the gut microbiota and host metabolism

1 reference

12 December 2020

Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH.

1 reference

12 December 2020

Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-alcoholic fatty liver disease

1 reference

12 December 2020

Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications.

1 reference

12 December 2020

Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice.

1 reference

12 December 2020

The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension

1 reference

12 December 2020

Duodenal infusion of donor feces for recurrent Clostridium difficile

1 reference

12 December 2020

Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment

1 reference

12 December 2020

Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist

1 reference

12 December 2020

Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study

1 reference

12 December 2020

Intestinal microbiota in patients with nonalcoholic fatty liver disease.

1 reference

12 December 2020

Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease

1 reference

12 December 2020

NAFLD in Asia--as common and important as in the West

1 reference

12 December 2020

Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy

1 reference

12 December 2020

Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease

1 reference

12 December 2020

Effect of Lactitol and Lactulose Administration on the Fecal Flora in Cirrhotic Patients

1 reference

12 December 2020

The global NAFLD epidemic

1 reference

12 December 2020

Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity.

1 reference

12 December 2020

Role of the intestinal microbiome in liver disease

1 reference

12 December 2020

The microbiome and cancer

1 reference

12 December 2020

Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.

1 reference

12 December 2020

Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial

1 reference

12 December 2020

Differential effects of antibiotic therapy on the structure and function of human gut microbiota

1 reference

12 December 2020

Diet rapidly and reproducibly alters the human gut microbiome

1 reference

12 December 2020

Altered profile of human gut microbiome is associated with cirrhosis and its complications

1 reference

12 December 2020

Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study

1 reference

12 December 2020

Antibiotic treatments and microbes in the gut.

1 reference

12 December 2020

Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis

1 reference

12 December 2020

Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity

1 reference

12 December 2020

Oral probiotic VSL#3 attenuates the circulatory disturbances of patients with cirrhosis and ascites.

1 reference

12 December 2020

Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies

1 reference

12 December 2020

Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut

1 reference

12 December 2020

Role of toll-like receptors in immune activation and tolerance in the liver

1 reference

12 December 2020

Recovery of the gut microbiome following fecal microbiota transplantation

1 reference

12 December 2020

Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease

1 reference

12 December 2020

Controversies in the Diagnosis and Management of NAFLD and NASH.

1 reference

12 December 2020

Alterations of the human gut microbiome in liver cirrhosis

1 reference

12 December 2020

The global burden of liver disease: the major impact of China

1 reference

12 December 2020

Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice

1 reference

12 December 2020

Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice

1 reference

12 December 2020

Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis

1 reference

12 December 2020

Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial

1 reference

12 December 2020

Obesity, fatty liver disease and intestinal microbiota

1 reference

12 December 2020

Diet and feeding pattern affect the diurnal dynamics of the gut microbiome

1 reference

12 December 2020

Gut microbiota and metabolic syndrome

1 reference

12 December 2020

Prebiotics, probiotics, synbiotics, and the immune system: experimental data and clinical evidence

1 reference

12 December 2020

Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease

1 reference

12 December 2020

Gut microbiota and liver diseases

1 reference

12 December 2020

Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD.

1 reference

12 December 2020

New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics

1 reference

12 December 2020

Engineering the gut microbiota to treat hyperammonemia.

1 reference

12 December 2020

Lactobacillus acidophilus (Enpac) in Treatment of Hepatic Encephalopathy

1 reference

12 December 2020

Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease)

1 reference

12 December 2020

Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans

1 reference

12 December 2020

Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites

1 reference

12 December 2020

Influence of alcohol on gastrointestinal motility: lactulose breath hydrogen testing in orocecal transit time in chronic alcoholics, social drinkers and teetotaler subjects.

1 reference

12 December 2020

Steatohepatitis: a tale of two "hits"?

1 reference

12 December 2020

Identifiers

DOI

10.1055/S-0035-1571276

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6658186&resulttype=core&format=json

15 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6658186&resulttype=core&format=json

15 May 2020

26870931

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6658186&resulttype=core&format=json